SlideShare uma empresa Scribd logo
1 de 13
Bayesian Decision Making in
     Clinical Research

    Dr. Bhaswat S. Chakrabortya
 a
  R&D, Cadila Pharmaceuticals Ltd.,
    Ahemdabad, Gujarat 387 810
Abstract
•   Objective: To demonstrate various applications of Bayesian statistics in evaluating evidence from
    clinical and epidemiological research and understanding their implications in conclusions of clinical
    trials, medical practice, guidelines and policies.
•   Methods: Conventional (Frequentist) and Bayesian theories of probabilities are compared and
    contrasted. Inference of the results of a clinical trial comparing treatments A and B was considered.
    Conventional analysis concluded that treatment A is superior because there is a low probability that
    such a significant difference would have been observed when the treatments were in fact equal.
    Bayesian analysis on the other hand looked at the observed difference and induced the likelihood of
    treatment A being superior to B. A couple of additional case studies were also considered. In all
    cases, relative merits of the two approaches were analyzed for medical practice, guidelines and
    policies.
•   Results: The conventional analysis showed a p value for the difference between treatments A and B is
    0.001, which is highly significant at α = 0.05. This means that the chance of observing this difference
    when A and B are in fact equal is 1in 1000. The Bayesian conditioned probability of A being superior
    to B was 0.999. Although the same conclusion was reached here, the next two case studies (1.
    whether cancer can be induced by proximity to high-voltage transmission lines and 2. an increased
    risk of venous thrombosis with third generation oral contraceptives) showed very different results
    leading to different conclusions.
•   Conclusions: Conventional and Bayesian inferences can be similar or different but the key difference
    between conventional and Bayesian reasoning is that the Bayesian believes that truth is subjective and
    naturally conditioned by the evidence. Almost all areas of clinical research and medicine now have
    applications of Bayesian statistics, one of the earliest being diagnostic medicine. From the results of
    the case studies, we shall also see the application of Bayesian methods clinical trials and
    epidemiology.
Rev. Thomas Bayes (1702-1761)
               •   Rev. Thomas Bayes noted that
                   sometimes the probability of a
                   statistical hypothesis is given before
                   event or evidence is observed
                   (Prior); he showed how to compute
                   the probability of the hypothesis
                   after some observations are made
                   (Posterior).

               •   Before Rev. Bayes, no one knew
                   how to measure the probability of
                   statistical hypotheses in the light of
                   data. Only it was known as to how
                   to reject a statistical hypothesis in
                   the light of data.
Bayes' Theorem
Let X1, X2, ... , Xn be a set of mutually exclusive events that
form the sample space S. Let Y be any event from the same
sample space, such that P(Y) > 0. Then,
                                    P( Xk ∩ Y )
    P( Xk | Y ) =                                                   ….Eq. 1
                     P( X1 ∩ Y ) + P( X2 ∩ Y ) + P( X3 ∩ Y )

Since P( Xk ∩ Y ) = P( Xk )*P( Y | Xk ), Bayes’ theorem can
also be expressed as
P( Xk | Y ) =                      P( Xk )*P( Y | Xk )
                P( X1 )*P( Y | X1 ) + P( X2 )*P( Y | X2 ) P( Xn )*P( Y | Xn )

                                                                  ….Eq. 2
Case Study 1 – A Superiority Trial:
        Conventional Statistics
• H0 : μA – μB ≤ δ
• H1 : μA – μB > δ
• The hypotheses were tested at level of significance α
  =0.05
• Experimental data was analyzed to find p = 0.001
   – (i.e., the probability of observing this difference by chance
     is 1 in 1000)
• The Null Hypothesis was rejected (conclusion:
  alternate is true – A is superior to B)
Case Study 1 – A Superiority Trial:
             Bayes’ Statistics
•   Let prior probability Treatment A being superior to Treatment B, P( X A ) =
    0.8
•   and, therefore, prior probability Treatment A NOT being superior to
    Treatment B, P( XB ) = 0.2
•   Let experimental (RCTs) probability of concluding A is superior to B,
    when A is indeed superior, P(Y | XA) = 0.95
•   and, therefore, experimental probability of concluding A NOT being
    superior to B, when A is indeed superior, P(Y | X B) = 0.05
•   What we would like to know is the posterior or conditional probability of
    A indeed being superior to B when the experimental evidence is
    superiority of A (following Eq. 2):
      P( XA | Y ) =                  P( XA )*P( Y | XA )
                           P( XA )*P( Y | XA ) + P( XB )*P( Y | XB )
A Superiority Trial:
                Bayes’ Statistics contd.
                               P( XA )*P( Y | XA )
     P( XA | Y ) =
                      P( XA )*P( Y | XA ) + P( XB )*P( Y | XB )

                =              0.8*0.95
                          0.8*0.95 + 0.2*0.05


                =              0.76
                            0.76 + 0.01

                =              0.99
That is a 99% probability of the hypothesis that A is Superior to
  B!
Case Study 2
•   Case and the Problem
     – An elementary school staff was concerned that their high cancer rate could be
        due to two nearby high voltage transmission lines [1]

•   Data
     – there were 8 cases of invasive cancer over a long time among 145 staff
        members whose average age was between 40 and 44
     – based on the national cancer rate among woman this age
        (approximately 3/100), the expected number of cancers is 4.2

•   Assumptions
     – the 145 staff members developed cancer independently of each other
     – the chance of cancer, θ, was the same for each staff person

•   Therefore, the number of cancers, X, follows a binomial distribution:
     – X ~ bin (145, θ)
     – θ could be 0.03 (national cancer rate) or more, i.e., 0.04, 0.05, 0.06
Case Study 2 contd.
•   For each hypothesized θ, we use elementary results about the binomial
    distribution to calculate:

                           145
          P(X=8 | θ) =            θ8 (1 – θ)137
                            8
•   Theory A: P(X=8 | θ=0.03 ) ≈ 0.036; Theory B: P(X=8 | θ=0.04 ) ≈ 0.096
•   Theory C: P(X=8 | θ=0.05 ) ≈ 0.134; Theory D: P(X=8 | θ=0.06 ) ≈ 0.136
•   This is a ratio of approximately 1:3:4:4. So, Theory B explains the data
    about 3 times as well as theory A
•   Likelihood Principle:
     – Initially, P( X | θ ) is a function of two variables: X and θ.
     – But once X = 8 has been observed, then P( X | θ ) describes how well each
         theory, or value of θ explains the data. No other value of X is relevant.
     –   This is an example of the likelihood principal[2]
Case Study 2 contd..
•   Conventional Analysis:
•   Null hypothesis, H0: θ=0.03; Alternate hypothesis, H1: θ=0.03
•   p-value = P(X=8| θ=0.03)+ P(X=9| θ=0.03)+ +…+ P(X=145| θ=0.03)
              ≈ 0.07
•   At α=0.10, the null hypothesis will be rejected and conclusion would be
    that the high voltage has a significant effect on the cancer rate at the school


•   Bayesian Analysis:
•   P(A | X=8 ) = 0.23; P( B | X=8 ) = 0.21
•   P( C | X=8 ) = 0.28; P( D | X=8 ) = 0.28
•   The Bayesian P(θ > .03) ≈ 0.77, which would not be sufficient
    to reject the null hypothesis!!
Case Study 3
•   Case and the Problem
     – Four case-control studies (one nested in a cohort study) of third generation
         contraceptive pills containing desogestral and gestodene were compared with
         pills containing other progestagens for the relative risk of venous
         thromboembolism[3].
•   Bayesian Analysis:
     –   Showed the posterior distributions are much narrower than the prior distributions,
         indicating less doubt about the value of the true relative risk (odds ratio of 2.0).
         The data influenced the posterior distributions more than the prior distributions, such
         that they are centred on log(1.69) and log(1.76) respectively, and the probability of
         the true relative risk being greater than 1 is more than 0.999 in both cases.
•   Why was not this risk picked up by conventional analysis?
     –   As we illustrated in previous examples, conventional analysis does not calculate the
         probability of a hypothesis being true given the data
•   The real scientific question could have been:
     – "What is the probability that the third generation pills increase the risk when
         compared to the others; what is the probability that they at least double the
         risk--as measured in the case-control study; and what is the 'median estimate'
         (as likely to be too small as too large)?" [4]
Conclusions
•   Conventional Statistics (Frequentists) make no claims about probabilities
     – E.g., the 95% CI of mean does not claim there is a 95% probability the mean is in that
       range
     – It only states that if the experiment was repeated 100 times, 95 times the estimated mean
       would lie that range
•   Likelihood also does not give you probability of a hypothesis – only the likelihood
    of the data given the hypothesis
•   Bayesian Statistics does give you the probability of a hypothesis being true given
    the data
     – This is closest to intuition and normal process of decision making
•   Three case studies
     – The first one shows, if the prior and posterior are equally influenced by data, then the
       conventional and Bayesian conclusions are nominally the same
     – However, in the second case, the conditioned (posterior) probability, although influenced
       by the data, did not yet call for a rejection of the hypothesis
     – And in the third case, the data changed the posterior probability so much that only the
       conditioned hypothesis was considered to be true
References

1. Brodeur P, “The Cancer at Slater School”, Annals of radiation,
   The New Yorker, December 7, 1992, p. 86.
2. http://www.home.uchicago.edu/~grynav/bayes/ABSLec1.ppt,
   access date 06.03.2009.
3. McPherson K. Third Generation Oral Contraception and
   Venous Thromboembolism. BMJ, 1995, 312, 68-9.
4. Lilford RJ, Braunholtz D. The Statistical Basis of Public
   Policy: a Paradigm Shift is Overdue. BMJ, 1996, 313, pp. 603-
   7.

Mais conteúdo relacionado

Mais procurados

Biostatistics in Clinical Research
Biostatistics in Clinical ResearchBiostatistics in Clinical Research
Biostatistics in Clinical ResearchAbhaya Indrayan
 
Basics of Systematic Review and Meta-analysis: Part 2
Basics of Systematic Review and Meta-analysis: Part 2Basics of Systematic Review and Meta-analysis: Part 2
Basics of Systematic Review and Meta-analysis: Part 2Rizwan S A
 
Signal detection and management
Signal detection and managementSignal detection and management
Signal detection and managementsekharbabu41
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute RiskTauseef Jawaid
 
Overview Of Ich New E9
Overview Of Ich New E9Overview Of Ich New E9
Overview Of Ich New E9Jay1818mar
 
Introduction to meta-analysis (1612_MA_workshop)
Introduction to meta-analysis (1612_MA_workshop)Introduction to meta-analysis (1612_MA_workshop)
Introduction to meta-analysis (1612_MA_workshop)Ahmed Negida
 
Sources of bias and error
Sources of bias and error Sources of bias and error
Sources of bias and error IAU Dent
 
observational analytical study
observational analytical studyobservational analytical study
observational analytical studyDr. Partha Sarkar
 
Enabling Risk Management: From Safety Signal to Risk/Benefit Management
Enabling Risk Management: From Safety Signal to Risk/Benefit ManagementEnabling Risk Management: From Safety Signal to Risk/Benefit Management
Enabling Risk Management: From Safety Signal to Risk/Benefit ManagementUntil ROI
 
Error, confounding and bias
Error, confounding and biasError, confounding and bias
Error, confounding and biasAmandeep Kaur
 
Clinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-StatisticiansClinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-StatisticiansBrook White, PMP
 
Placebo effects – clinical data
Placebo effects – clinical dataPlacebo effects – clinical data
Placebo effects – clinical dataYasir Hameed
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial designUrmila Aswar
 
Careers In Clinical Research
Careers In Clinical ResearchCareers In Clinical Research
Careers In Clinical ResearchKhyati Dholakia
 
Cross sectional study-dr.wah
Cross sectional study-dr.wahCross sectional study-dr.wah
Cross sectional study-dr.wahMmedsc Hahm
 

Mais procurados (20)

Biostatistics in Clinical Research
Biostatistics in Clinical ResearchBiostatistics in Clinical Research
Biostatistics in Clinical Research
 
Basics of Systematic Review and Meta-analysis: Part 2
Basics of Systematic Review and Meta-analysis: Part 2Basics of Systematic Review and Meta-analysis: Part 2
Basics of Systematic Review and Meta-analysis: Part 2
 
Signal detection and management
Signal detection and managementSignal detection and management
Signal detection and management
 
Survival analysis
Survival  analysisSurvival  analysis
Survival analysis
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute Risk
 
Clinical prediction models
Clinical prediction modelsClinical prediction models
Clinical prediction models
 
Overview Of Ich New E9
Overview Of Ich New E9Overview Of Ich New E9
Overview Of Ich New E9
 
09 selection bias
09 selection bias09 selection bias
09 selection bias
 
Introduction to meta-analysis (1612_MA_workshop)
Introduction to meta-analysis (1612_MA_workshop)Introduction to meta-analysis (1612_MA_workshop)
Introduction to meta-analysis (1612_MA_workshop)
 
Designs of clinical trials
Designs of clinical trialsDesigns of clinical trials
Designs of clinical trials
 
Sources of bias and error
Sources of bias and error Sources of bias and error
Sources of bias and error
 
observational analytical study
observational analytical studyobservational analytical study
observational analytical study
 
Enabling Risk Management: From Safety Signal to Risk/Benefit Management
Enabling Risk Management: From Safety Signal to Risk/Benefit ManagementEnabling Risk Management: From Safety Signal to Risk/Benefit Management
Enabling Risk Management: From Safety Signal to Risk/Benefit Management
 
Error, confounding and bias
Error, confounding and biasError, confounding and bias
Error, confounding and bias
 
Clinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-StatisticiansClinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-Statisticians
 
Placebo effects – clinical data
Placebo effects – clinical dataPlacebo effects – clinical data
Placebo effects – clinical data
 
Randomisation
RandomisationRandomisation
Randomisation
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Careers In Clinical Research
Careers In Clinical ResearchCareers In Clinical Research
Careers In Clinical Research
 
Cross sectional study-dr.wah
Cross sectional study-dr.wahCross sectional study-dr.wah
Cross sectional study-dr.wah
 

Semelhante a Bayesian Decision Making in Clinical Research

Bayesian statistics using r intro
Bayesian statistics using r   introBayesian statistics using r   intro
Bayesian statistics using r introBayesLaplace1
 
blood_red_demo.pptx
blood_red_demo.pptxblood_red_demo.pptx
blood_red_demo.pptxBruceHuang41
 
On the vexing dilemma of hypothesis testing and the predicted demise of the B...
On the vexing dilemma of hypothesis testing and the predicted demise of the B...On the vexing dilemma of hypothesis testing and the predicted demise of the B...
On the vexing dilemma of hypothesis testing and the predicted demise of the B...Christian Robert
 
2.statistical DEcision makig.pptx
2.statistical DEcision makig.pptx2.statistical DEcision makig.pptx
2.statistical DEcision makig.pptxImpanaR2
 
Philosophy of Science and Philosophy of Statistics
Philosophy of Science and Philosophy of StatisticsPhilosophy of Science and Philosophy of Statistics
Philosophy of Science and Philosophy of Statisticsjemille6
 
Phil 6334 Mayo slides Day 1
Phil 6334 Mayo slides Day 1Phil 6334 Mayo slides Day 1
Phil 6334 Mayo slides Day 1jemille6
 
Test of-significance : Z test , Chi square test
Test of-significance : Z test , Chi square testTest of-significance : Z test , Chi square test
Test of-significance : Z test , Chi square testdr.balan shaikh
 
The Statistics Wars: Errors and Casualties
The Statistics Wars: Errors and CasualtiesThe Statistics Wars: Errors and Casualties
The Statistics Wars: Errors and Casualtiesjemille6
 
hypotesting lecturenotes by Amity university
hypotesting lecturenotes by Amity universityhypotesting lecturenotes by Amity university
hypotesting lecturenotes by Amity universitydeepti .
 

Semelhante a Bayesian Decision Making in Clinical Research (20)

Bayesian statistics using r intro
Bayesian statistics using r   introBayesian statistics using r   intro
Bayesian statistics using r intro
 
blood_red_demo.pptx
blood_red_demo.pptxblood_red_demo.pptx
blood_red_demo.pptx
 
Basic of Hypothesis Testing TEKU QM
Basic of Hypothesis Testing TEKU QMBasic of Hypothesis Testing TEKU QM
Basic of Hypothesis Testing TEKU QM
 
Test of significance
Test of significanceTest of significance
Test of significance
 
On the vexing dilemma of hypothesis testing and the predicted demise of the B...
On the vexing dilemma of hypothesis testing and the predicted demise of the B...On the vexing dilemma of hypothesis testing and the predicted demise of the B...
On the vexing dilemma of hypothesis testing and the predicted demise of the B...
 
Lec13_Bayes.pptx
Lec13_Bayes.pptxLec13_Bayes.pptx
Lec13_Bayes.pptx
 
Bayesian ijupls
Bayesian ijuplsBayesian ijupls
Bayesian ijupls
 
2.statistical DEcision makig.pptx
2.statistical DEcision makig.pptx2.statistical DEcision makig.pptx
2.statistical DEcision makig.pptx
 
Philosophy of Science and Philosophy of Statistics
Philosophy of Science and Philosophy of StatisticsPhilosophy of Science and Philosophy of Statistics
Philosophy of Science and Philosophy of Statistics
 
Bayesian data analysis1
Bayesian data analysis1Bayesian data analysis1
Bayesian data analysis1
 
Phil 6334 Mayo slides Day 1
Phil 6334 Mayo slides Day 1Phil 6334 Mayo slides Day 1
Phil 6334 Mayo slides Day 1
 
Test of-significance : Z test , Chi square test
Test of-significance : Z test , Chi square testTest of-significance : Z test , Chi square test
Test of-significance : Z test , Chi square test
 
The Statistics Wars: Errors and Casualties
The Statistics Wars: Errors and CasualtiesThe Statistics Wars: Errors and Casualties
The Statistics Wars: Errors and Casualties
 
hypotesting lecturenotes by Amity university
hypotesting lecturenotes by Amity universityhypotesting lecturenotes by Amity university
hypotesting lecturenotes by Amity university
 
Gerstman_PP09.ppt
Gerstman_PP09.pptGerstman_PP09.ppt
Gerstman_PP09.ppt
 
Gerstman_PP09.ppt
Gerstman_PP09.pptGerstman_PP09.ppt
Gerstman_PP09.ppt
 
Ppt1
Ppt1Ppt1
Ppt1
 
Hypothesis Testing
Hypothesis TestingHypothesis Testing
Hypothesis Testing
 
unit 3 -ML.pptx
unit 3 -ML.pptxunit 3 -ML.pptx
unit 3 -ML.pptx
 
Bayes' theorem
Bayes' theoremBayes' theorem
Bayes' theorem
 

Mais de Bhaswat Chakraborty

Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Bhaswat Chakraborty
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Bhaswat Chakraborty
 
Respiratory studies right approach in designs dia 11 april 2019 r
Respiratory studies right approach  in designs dia 11 april 2019 rRespiratory studies right approach  in designs dia 11 april 2019 r
Respiratory studies right approach in designs dia 11 april 2019 rBhaswat Chakraborty
 
Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...Bhaswat Chakraborty
 
Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019 Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019 Bhaswat Chakraborty
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Bhaswat Chakraborty
 
Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018Bhaswat Chakraborty
 
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. ChakrabortyMultidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. ChakrabortyBhaswat Chakraborty
 
Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018Bhaswat Chakraborty
 
Orientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy ProgramsOrientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy ProgramsBhaswat Chakraborty
 
Plagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid PlagiarismPlagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid PlagiarismBhaswat Chakraborty
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Bhaswat Chakraborty
 
Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development Bhaswat Chakraborty
 
Clinical Development of Biosimilars
Clinical Development of Biosimilars Clinical Development of Biosimilars
Clinical Development of Biosimilars Bhaswat Chakraborty
 
Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials Bhaswat Chakraborty
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBhaswat Chakraborty
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBhaswat Chakraborty
 
Protein binding of drugs and screening of drugs by physicochemical properties
Protein binding of drugs  and screening of drugs by physicochemical propertiesProtein binding of drugs  and screening of drugs by physicochemical properties
Protein binding of drugs and screening of drugs by physicochemical propertiesBhaswat Chakraborty
 
Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity Bhaswat Chakraborty
 

Mais de Bhaswat Chakraborty (20)

Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019
 
Respiratory studies right approach in designs dia 11 april 2019 r
Respiratory studies right approach  in designs dia 11 april 2019 rRespiratory studies right approach  in designs dia 11 april 2019 r
Respiratory studies right approach in designs dia 11 april 2019 r
 
Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...
 
Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019 Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
 
Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018
 
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. ChakrabortyMultidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
 
Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018
 
Orientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy ProgramsOrientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy Programs
 
Plagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid PlagiarismPlagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid Plagiarism
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
 
Ethics in Pharmacy
Ethics in Pharmacy Ethics in Pharmacy
Ethics in Pharmacy
 
Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development
 
Clinical Development of Biosimilars
Clinical Development of Biosimilars Clinical Development of Biosimilars
Clinical Development of Biosimilars
 
Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
 
Protein binding of drugs and screening of drugs by physicochemical properties
Protein binding of drugs  and screening of drugs by physicochemical propertiesProtein binding of drugs  and screening of drugs by physicochemical properties
Protein binding of drugs and screening of drugs by physicochemical properties
 
Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity
 

Último

Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...astropune
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Call Girls in Nagpur High Profile
 
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiAlinaDevecerski
 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...perfect solution
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...aartirawatdelhi
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeCall Girls Delhi
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...hotbabesbook
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...indiancallgirl4rent
 
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋TANUJA PANDEY
 

Último (20)

Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
 
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bangalore Just Call 9907093804 Top Class Call Girl Service Available
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
 
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
 

Bayesian Decision Making in Clinical Research

  • 1. Bayesian Decision Making in Clinical Research Dr. Bhaswat S. Chakrabortya a R&D, Cadila Pharmaceuticals Ltd., Ahemdabad, Gujarat 387 810
  • 2. Abstract • Objective: To demonstrate various applications of Bayesian statistics in evaluating evidence from clinical and epidemiological research and understanding their implications in conclusions of clinical trials, medical practice, guidelines and policies. • Methods: Conventional (Frequentist) and Bayesian theories of probabilities are compared and contrasted. Inference of the results of a clinical trial comparing treatments A and B was considered. Conventional analysis concluded that treatment A is superior because there is a low probability that such a significant difference would have been observed when the treatments were in fact equal. Bayesian analysis on the other hand looked at the observed difference and induced the likelihood of treatment A being superior to B. A couple of additional case studies were also considered. In all cases, relative merits of the two approaches were analyzed for medical practice, guidelines and policies. • Results: The conventional analysis showed a p value for the difference between treatments A and B is 0.001, which is highly significant at α = 0.05. This means that the chance of observing this difference when A and B are in fact equal is 1in 1000. The Bayesian conditioned probability of A being superior to B was 0.999. Although the same conclusion was reached here, the next two case studies (1. whether cancer can be induced by proximity to high-voltage transmission lines and 2. an increased risk of venous thrombosis with third generation oral contraceptives) showed very different results leading to different conclusions. • Conclusions: Conventional and Bayesian inferences can be similar or different but the key difference between conventional and Bayesian reasoning is that the Bayesian believes that truth is subjective and naturally conditioned by the evidence. Almost all areas of clinical research and medicine now have applications of Bayesian statistics, one of the earliest being diagnostic medicine. From the results of the case studies, we shall also see the application of Bayesian methods clinical trials and epidemiology.
  • 3. Rev. Thomas Bayes (1702-1761) • Rev. Thomas Bayes noted that sometimes the probability of a statistical hypothesis is given before event or evidence is observed (Prior); he showed how to compute the probability of the hypothesis after some observations are made (Posterior). • Before Rev. Bayes, no one knew how to measure the probability of statistical hypotheses in the light of data. Only it was known as to how to reject a statistical hypothesis in the light of data.
  • 4. Bayes' Theorem Let X1, X2, ... , Xn be a set of mutually exclusive events that form the sample space S. Let Y be any event from the same sample space, such that P(Y) > 0. Then, P( Xk ∩ Y ) P( Xk | Y ) = ….Eq. 1 P( X1 ∩ Y ) + P( X2 ∩ Y ) + P( X3 ∩ Y ) Since P( Xk ∩ Y ) = P( Xk )*P( Y | Xk ), Bayes’ theorem can also be expressed as P( Xk | Y ) = P( Xk )*P( Y | Xk ) P( X1 )*P( Y | X1 ) + P( X2 )*P( Y | X2 ) P( Xn )*P( Y | Xn ) ….Eq. 2
  • 5. Case Study 1 – A Superiority Trial: Conventional Statistics • H0 : μA – μB ≤ δ • H1 : μA – μB > δ • The hypotheses were tested at level of significance α =0.05 • Experimental data was analyzed to find p = 0.001 – (i.e., the probability of observing this difference by chance is 1 in 1000) • The Null Hypothesis was rejected (conclusion: alternate is true – A is superior to B)
  • 6. Case Study 1 – A Superiority Trial: Bayes’ Statistics • Let prior probability Treatment A being superior to Treatment B, P( X A ) = 0.8 • and, therefore, prior probability Treatment A NOT being superior to Treatment B, P( XB ) = 0.2 • Let experimental (RCTs) probability of concluding A is superior to B, when A is indeed superior, P(Y | XA) = 0.95 • and, therefore, experimental probability of concluding A NOT being superior to B, when A is indeed superior, P(Y | X B) = 0.05 • What we would like to know is the posterior or conditional probability of A indeed being superior to B when the experimental evidence is superiority of A (following Eq. 2): P( XA | Y ) = P( XA )*P( Y | XA ) P( XA )*P( Y | XA ) + P( XB )*P( Y | XB )
  • 7. A Superiority Trial: Bayes’ Statistics contd. P( XA )*P( Y | XA ) P( XA | Y ) = P( XA )*P( Y | XA ) + P( XB )*P( Y | XB ) = 0.8*0.95 0.8*0.95 + 0.2*0.05 = 0.76 0.76 + 0.01 = 0.99 That is a 99% probability of the hypothesis that A is Superior to B!
  • 8. Case Study 2 • Case and the Problem – An elementary school staff was concerned that their high cancer rate could be due to two nearby high voltage transmission lines [1] • Data – there were 8 cases of invasive cancer over a long time among 145 staff members whose average age was between 40 and 44 – based on the national cancer rate among woman this age (approximately 3/100), the expected number of cancers is 4.2 • Assumptions – the 145 staff members developed cancer independently of each other – the chance of cancer, θ, was the same for each staff person • Therefore, the number of cancers, X, follows a binomial distribution: – X ~ bin (145, θ) – θ could be 0.03 (national cancer rate) or more, i.e., 0.04, 0.05, 0.06
  • 9. Case Study 2 contd. • For each hypothesized θ, we use elementary results about the binomial distribution to calculate: 145 P(X=8 | θ) = θ8 (1 – θ)137 8 • Theory A: P(X=8 | θ=0.03 ) ≈ 0.036; Theory B: P(X=8 | θ=0.04 ) ≈ 0.096 • Theory C: P(X=8 | θ=0.05 ) ≈ 0.134; Theory D: P(X=8 | θ=0.06 ) ≈ 0.136 • This is a ratio of approximately 1:3:4:4. So, Theory B explains the data about 3 times as well as theory A • Likelihood Principle: – Initially, P( X | θ ) is a function of two variables: X and θ. – But once X = 8 has been observed, then P( X | θ ) describes how well each theory, or value of θ explains the data. No other value of X is relevant. – This is an example of the likelihood principal[2]
  • 10. Case Study 2 contd.. • Conventional Analysis: • Null hypothesis, H0: θ=0.03; Alternate hypothesis, H1: θ=0.03 • p-value = P(X=8| θ=0.03)+ P(X=9| θ=0.03)+ +…+ P(X=145| θ=0.03) ≈ 0.07 • At α=0.10, the null hypothesis will be rejected and conclusion would be that the high voltage has a significant effect on the cancer rate at the school • Bayesian Analysis: • P(A | X=8 ) = 0.23; P( B | X=8 ) = 0.21 • P( C | X=8 ) = 0.28; P( D | X=8 ) = 0.28 • The Bayesian P(θ > .03) ≈ 0.77, which would not be sufficient to reject the null hypothesis!!
  • 11. Case Study 3 • Case and the Problem – Four case-control studies (one nested in a cohort study) of third generation contraceptive pills containing desogestral and gestodene were compared with pills containing other progestagens for the relative risk of venous thromboembolism[3]. • Bayesian Analysis: – Showed the posterior distributions are much narrower than the prior distributions, indicating less doubt about the value of the true relative risk (odds ratio of 2.0). The data influenced the posterior distributions more than the prior distributions, such that they are centred on log(1.69) and log(1.76) respectively, and the probability of the true relative risk being greater than 1 is more than 0.999 in both cases. • Why was not this risk picked up by conventional analysis? – As we illustrated in previous examples, conventional analysis does not calculate the probability of a hypothesis being true given the data • The real scientific question could have been: – "What is the probability that the third generation pills increase the risk when compared to the others; what is the probability that they at least double the risk--as measured in the case-control study; and what is the 'median estimate' (as likely to be too small as too large)?" [4]
  • 12. Conclusions • Conventional Statistics (Frequentists) make no claims about probabilities – E.g., the 95% CI of mean does not claim there is a 95% probability the mean is in that range – It only states that if the experiment was repeated 100 times, 95 times the estimated mean would lie that range • Likelihood also does not give you probability of a hypothesis – only the likelihood of the data given the hypothesis • Bayesian Statistics does give you the probability of a hypothesis being true given the data – This is closest to intuition and normal process of decision making • Three case studies – The first one shows, if the prior and posterior are equally influenced by data, then the conventional and Bayesian conclusions are nominally the same – However, in the second case, the conditioned (posterior) probability, although influenced by the data, did not yet call for a rejection of the hypothesis – And in the third case, the data changed the posterior probability so much that only the conditioned hypothesis was considered to be true
  • 13. References 1. Brodeur P, “The Cancer at Slater School”, Annals of radiation, The New Yorker, December 7, 1992, p. 86. 2. http://www.home.uchicago.edu/~grynav/bayes/ABSLec1.ppt, access date 06.03.2009. 3. McPherson K. Third Generation Oral Contraception and Venous Thromboembolism. BMJ, 1995, 312, 68-9. 4. Lilford RJ, Braunholtz D. The Statistical Basis of Public Policy: a Paradigm Shift is Overdue. BMJ, 1996, 313, pp. 603- 7.